Vanda Pharmaceuticals Inc...

NASDAQ: VNDA · Real-Time Price · USD
4.56
0.20 (4.59%)
At close: Aug 18, 2025, 3:59 PM
4.40
-3.55%
Pre-market: Aug 19, 2025, 04:24 AM EDT

Vanda Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-18.9M 2.51M 6.28M 33.15M
Depreciation & Amortization
8.13M 3.01M 2.73M 2.84M
Stock-Based Compensation
12.43M 14.04M 16.28M 15.37M
Other Working Capital
4.78M 11.71M -151K 4.4M
Other Non-Cash Items
-4.38M -4.72M -507K 3.37M
Deferred Income Tax
-6.48M -1.29M 1.13M 6.75M
Change in Working Capital
-6.56M -747K 6.07M 2.74M
Operating Cash Flow
-15.76M 12.8M 31.98M 64.21M
Capital Expenditures
-490K -383K -679K -552K
Cash Acquisitions
-4.23M -100.67M -50.6M -12K
Purchase of Investments
-364.77M -512.61M -349.26M -420.46M
Sales Maturities Of Investments
352.06M 601.6M 399.86M 344.32M
Other Investing Acitivies
n/a n/a 50.6M 12K
Investing Cash Flow
-17.43M -12.06M 49.92M -76.7M
Debt Repayment
-155K n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 734K 3.55M
Financial Cash Flow
-155K n/a 734K 3.55M
Net Cash Flow
-33.51M 792K 82.91M -9.02M
Free Cash Flow
-16.25M 12.42M 31.3M 63.66M